The Cleveland Clinic has removed a cardiologist for failing to disclose his financial interest in a stroke-preventing device that he invented and reviewed positively in a national study, a clinic spokeswoman said Friday.
Dr. Jay Yadav and others sold rights to the device, Angioguard, to Cordis Corp., a division of New Brunswick, N.J.-based Johnson & Johnson, in 1999 in a deal worth $40 million, plus royalties, The Plain Dealer reported in Friday’s editions.
Yadav failed to properly disclose that fact to the clinic and the FDA during clinical reviews of Angioguard, the newspaper reported.
More
No comments:
Post a Comment